- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Zydus Lifesciences Limited — Updates, 08-04-2026: Press Release
08-04-2026 | 09:44 am
08-04-2026 | 09:44 am
Zydus received USFDA approval for Dapagliflozin Tablets (5mg, 10mg), targeting a USD 10.2bn US market. This allows market entry for the type 2 diabetes drug, manufactured at its Ahmedabad facility.
No comments yet. Be the first to comment!